STAT+: Detailed data show Pfizer’s monthly obesity drug continues to show potential

How 1 sources are covering this

• STATCenter·1h ago

  STAT+: Detailed data show Pfizer’s monthly obesity drug continues to show potential

  Detailed data from a midstage study offered further evidence that the obesity drug Pfizer acquired from the biotech Metsera could be dosed monthly.

  Read at STAT →